Poll

Poll: Assessing Depression and CV Risk in PsA

07/23/2020

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

News

FDA Grants Orphan Drug Designation to Efzofitimod for Systemic Sclerosis

04/19/2022

The new immunomodulator outperformed existing antifibrotic agents in animal models.

The new immunomodulator...

04/19/2022

Rheumatology & Arthritis

Primary Care

Referring Patients to a Rheumatologist

05/20/2022

In this video, Monica Richey, MSN, NP, speaks about when a primary care provider should refer a patient to a rheumatologist, including how to expedite the process.

In this video, Monica Richey,...

05/20/2022

Rheumatology & Arthritis

News

Low-Dose Prednisolone Benefits Older Adults With RA

06/30/2011

A favorable risk-benefit balance was found for older adults with rheumatoid arthritis who received low-dose prednisolone for up to 2 years.

A favorable risk-benefit balance...

06/30/2011

Rheumatology & Arthritis

News

Planning, Management Key to Positive Pregnancy Outcomes in axSpA

09/01/2022

An analysis of pregnancy registries showed that among women with axial spondyloarthritis who received preconception counseling and tight management, most outcomes were similar to those for the general population.

An analysis of pregnancy...

09/01/2022

Rheumatology & Arthritis

Podcast

Alexis Ogdie, MD, on Adverse Effects of Methotrexate in PsA

02/28/2023

Dr Ogdie discusses her research into the differences in reactions to methotrexate and tumor necrosis factor inhibitors among patients with psoriatic arthritis and rheumatoid arthritis.

Dr Ogdie discusses her research...

02/28/2023

Rheumatology & Arthritis

Poll: Assessing Depression and CV Risk in PsA

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products